Overall, studies consistently demonstrate the critical importance of T lymphocytes, particularly CD8+ T cells, in osteosarcoma treatment, highlighting their influence in impeding tumor development and metastatic development within a complex immunosuppressive environment. Here, CD8A is linked to osteosarcoma.